🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy, such as doxorubicin hydrochloride, b...
Status
Terminated
Location
Stanford Cancer Center
Start Date
2013-05-24
Trial ID
NCT01390584
The first testing of TargomiRs in the human setting: dose-finding studies i...
Status
Completed
Location
Concord Repatriation General Hospital
Start Date
2014-09
Trial ID
NCT02369198
Treatments Being Tested
Aim and objectives: This trial aims to evaluate the role of adjuvant radio...
Status
Active Not Recruiting
Location
Tata Memorial Centre
Start Date
2016-06-02
Trial ID
NCT02951325
Treatments Being Tested
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-12-15
Trial ID
NCT06043713
This phase I trial studies the side effects and best dose of genetically mo...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2015-05-18
Trial ID
NCT02208362
Treatments Being Tested
This is a prospective investigation which aims to address key challenges to...
Status
Completed
Location
University of Wisconsin
Start Date
2021-09-13
Trial ID
NCT04818060
Treatments Being Tested
This study aimed to determine the effects of mindfulness-based stress reduc...
Status
Completed
Location
Ataturk University Faculty of Nursing
Start Date
2021-03-30
Trial ID
NCT07130227
Treatments Being Tested
The purpose of this study is to evaluate the change in the expression of tr...
Status
Active Not Recruiting
Location
Nebraska Cancer Specialists
Start Date
2024-07-29
Trial ID
NCT06379217
A3D is a phase I/II clinical trial. The primary objective is to evaluate th...
Status
Recruiting
Location
University Hospital of Toulouse
Start Date
2026-05-07
Trial ID
NCT07367815
This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin ...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2023-06-12
Trial ID
NCT05633615